Design and rationale for a pilot trial of D-alanine supplementation to reduce the triglyceride to high-density lipoprotein cholesterol ratio in patients with chronic kidney disease
This protocol was approved by the Clinical Trial Review Board of Nara Medical University Clinical Research Review Committee (CRB5200002) on February 5, 2025, and is available to the public on the website of the Japan Registry of Clinical Trials on December 18, 2024 (jRCTs051240262).
Authors
- Masashi Mita
- Hideo Tsushima
- Takaaki Kosugi (ORCID: https://orcid.org/0000-0003-3696-2263)
- Kazuhiko Tsuruya (ORCID: https://orcid.org/0000-0002-8390-2928)
- Masaru Matsui (ORCID: https://orcid.org/0000-0001-9646-6363)
- Wasako Tato (ORCID: https://orcid.org/0000-0002-9272-4334)
- Masahiro Eriguchi (ORCID: https://orcid.org/0000-0001-8422-7314)
- Masato Kasahara (ORCID: https://orcid.org/0000-0002-1833-9075)
- Takayuki Uemura
- Ken‐ichi Samejima (ORCID: https://orcid.org/0000-0001-8273-5155)
- Masatoshi Nishimoto (ORCID: https://orcid.org/0009-0006-2063-781X)
- Shunsuke Kitamura
Institutions
- National Archives and Records Administration (US)
- Kagami Crystal (Japan) (JP)
- Nara Medical University (JP)
Publication Details
- Journal
- BMC Nephrology
- Published
- 2025-11-24
- DOI
- https://doi.org/10.1186/s12882-025-04649-4
- Primary Topic
- Amino Acid Enzymes and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00